Yunxin Bo;Nobuko Nishimura;Mark H. Norman;Kate Ashton;Longbin Liu;Marian C. Bryan;Clarence Henderson Hale;Michael David Bartberger;Christopher Harold Fotsch;Michael Croghan;Roxanne Kay Kunz;Lewis Dale
发明人:
Kate Ashton,Michael David Bartberger,Yunxin Bo,Marian C. Bryan,Michael Croghan,Christopher Harold Fotsch,Clarence Henderson Hale,Roxanne Kay Kunz,Longbin Liu,Nobuko Nishimura,Mark H. Norman,Lewis Dale
申请号：
US13215914
公开号：
US20120225854A1
申请日:
2011.08.23
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof,that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
